OCULAR THERAPEUTIX, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.17 USD | +5.11% |
|
+30.03% | +38.34% |
| 04-18 | Health Care Flat on Rotation From Rate-Sensitive Sectors -- Health Care Roundup | DJ |
| 04-18 | Ocular Therapeutix Reports Positive Topline Data in Diabetic Retinopathy Trial; Shares Fall | MT |
Chart calendar Ocular Therapeutix, Inc.
2f16.4-XnEkAC6nDyV-3EudghtUqh3DeZErfhW-2YE7jYQN4.ztCgRShShUmZHqKS1JRT9y_W7kf9IvGbNLqsIoqoKqeH1KJ8NTbYAZY2tA~289e2b8e98fa99a5b57e0f141b67f6fa
Upcoming events on Ocular Therapeutix, Inc.
Past events on Ocular Therapeutix, Inc.
| 04/04/2024 | ASCRS Congress |
| 11/03/2024 20:05 | Q4 2023 Earnings Release |
| 29/11/2023 18:00 | Piper Sandler Healthcare Conference |
| 27/11/2023 17:30 | BTIG Ophthalmology Day |
| 15/11/2023 15:00 | Jefferies London Healthcare Conference |
| 07/11/2023 21:30 | Q3 2023 Earnings Call |
| 07/11/2023 21:01 | Q3 2023 Earnings Release |
| 27/09/2023 20:00 | Cantor Global Healthcare Conference |
| 13/09/2023 15:50 | Baird Global Healthcare Conference |
| 11/09/2023 | H.C. Wainwright Global Investment Conference |
| 16/08/2023 16:00 | H.C. Wainwright Ophthalmology Virtual Conference |
| 07/08/2023 21:30 | Q2 2023 Earnings Call |
| 07/08/2023 21:01 | Q2 2023 Earnings Release |
| 14/06/2023 13:30 | Annual General Meeting |
| 12/06/2023 13:30 | Clinical Trials Summit |
| 11/06/2023 00:03 | Clinical Trials Summit |
| 10/06/2023 23:29 | Clinical Trials Summit |
| 10/06/2023 17:44 | Clinical Trials Summit |
| 08/06/2023 17:30 | Jefferies Global Healthcare Conference |
| 15/05/2023 20:00 | JMP Securities Life Sciences Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 4,23 4,55 -7.07% | 17,4 23,4 -25.74% | 43,5 45,5 -4.26% | 51,5 50,9 1.13% | 58,4 59,4 -1.67% | 68,3 |
|
EBITDA Million USD | Released Forecast Spread | -83,3 -83,4 0.12% | -60,1 -62,0 3.11% | -75,6 -77,5 2.43% | -76,5 -70,0 -9.35% | -79,4 -80,4 1.26% | -85,3 |
|
EBIT Million USD | Released Forecast Spread | -85,8 -84,0 -2.17% | -62,8 -56,3 -11.55% | -78,0 -77,5 -0.64% | -78,7 -76,5 -2.8% | -82,4 -86,2 4.44% | -99,6 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -86,4 -82,5 -4.71% | -156 -73,5 -111.64% | -6,55 -21,3 69.27% | -71,0 -72,8 2.46% | -80,7 -78,9 -2.33% | -102 |
|
Net income Million USD | Released Forecast Spread | -86,4 -82,5 -4.71% | -156 -73,5 -111.64% | -6,55 -21,3 69.27% | -71,0 -72,5 2.03% | -80,7 -79,4 -1.63% | -101 |
|
EPS USD | Released Forecast Spread | -1,91 -1,77 -8.22% | -2,56 -1,18 -117.32% | -0,09 -0,27 66.97% | -0,97 -0,94 -3.74% | -1,01 -0,96 -5.21% | -0,87 |
| Announcement Date | 12/03/20 | 11/03/21 | 28/02/22 | 06/03/23 | 11/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 12,3 14,4 -14.75% | 13,2 14,0 -5.52% | 12,3 14,2 -13.91% | 12,0 14,3 -16.16% | 14,1 13,5 4.01% | 13,4 14,1 -5.12% | 15,2 14,7 3.64% | 15,1 15,2 -0.53% | 14,8 15,7 -5.77% | 15,4 | 16,5 | 17,5 | 19,0 | 23,8 |
|
EBITDA Million USD | Released Forecast Spread | -17,5 -19,0 8.02% | -17,3 -17,6 1.73% | -21,0 -18,0 -16.86% | -18,9 -20,0 5.65% | -22,1 -19,7 -12.01% | -19,9 -22,0 9.46% | -18,3 -21,0 12.74% | -20,5 | -23,0 | -22,0 | -19,0 | -15,0 | -12,0 | |
|
EBIT Million USD | Released Forecast Spread | -18,0 -17,9 -0.66% | -17,8 -17,5 -1.64% | -19,9 -17,8 -11.84% | -21,5 -19,4 -11.09% | -19,4 -20,1 3.59% | -22,5 -20,2 -11.87% | -20,6 -22,0 6.38% | -19,2 -21,4 10.31% | -20,0 -24,0 16.37% | -22,0 | -23,8 | -26,5 | -27,3 | -17,6 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -3,85 -18,1 78.79% | -12,5 -19,3 34.86% | -18,8 -19,0 0.99% | -24,2 -20,5 -17.91% | -15,5 -20,5 24.34% | -30,3 -20,9 -45.05% | -20,7 -23,8 13.01% | -0,52 -22,6 97.72% | -29,2 -27,4 -6.64% | -22,8 | -24,5 | -27,3 | -27,9 | -17,9 |
|
Net income Million USD | Released Forecast Spread | -3,85 -18,1 78.79% | -12,5 -19,3 34.86% | -18,8 -17,7 -5.78% | -24,2 -18,9 -28.17% | -15,5 -19,5 20.27% | -30,3 -20,8 -45.47% | -20,7 -23,8 13.01% | -0,52 -22,6 97.72% | -29,2 -26,5 -10.32% | -22,6 | -24,2 | -26,9 | -27,5 | -17,9 |
|
EPS USD | Released Forecast Spread | -0,05 -0,23 78.45% | -0,16 -0,25 36% | -0,24 -0,23 -4.35% | -0,31 -0,24 -30.25% | -0,24 -0,25 4% | -0,39 -0,27 -45.52% | -0,26 -0,30 14.28% | -0,01 -0,29 96.51% | -0,35 -0,30 -15.56% | -0,20 | -0,21 | -0,25 | -0,25 | -0,13 |
| Announcement Date | 28/02/22 | 09/05/22 | 08/08/22 | 07/11/22 | 06/03/23 | 08/05/23 | 07/08/23 | 07/11/23 | 11/03/24 | - | - | - | - | - |
More events
Past sector events for Ocular Therapeutix, Inc.
| 03/05/2024 12:07 | AARTI DRUGS LIMITED: Q4 2024 Earnings Release |
| 03/05/2024 11:00 | AMNEAL PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 | SCINOPHARM TAIWAN, LTD.: Q1 2024 Earnings Release (Projected) |
| 02/05/2024 | DEVA HOLDING: Q1 2024 Earnings Release (Projected) |
| 02/05/2024 21:01 | AMGEN INC.: Q1 2024 Earnings Release |
| 02/05/2024 18:43 | ALK-ABELLÓ A/S: Q1 2024 Earnings Release |
| 02/05/2024 12:30 | ORGANON & CO.: Q1 2024 Earnings Release |
| 02/05/2024 12:00 | BAUSCH HEALTH COMPANIES INC.: Q1 2024 Earnings Release |
| 02/05/2024 06:30 | NOVO NORDISK A/S: Q1 2024 Earnings Release |
| 01/05/2024 | GC BIOPHARMA CORP.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- OCUL Stock
- Calendar Ocular Therapeutix, Inc.
